About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Hematologic irAEs (VTEs)
By
Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities
FEATURING
Keith McCrae
By
Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities
FEATURING
Keith McCrae
106 views
March 17, 2022
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
19:49
Rush University Medical Center
COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…
Feat.
S. Jain
18:41
CHEST 2022 Coverage
Role of Anticoagulants and Antiplatelet Agents for Patients With COV…
Feat.
V. Balasubramanian
21:20
Cleveland Clinic Rheumatology
How do I Recognize and Treat the VEXAS Syndrome?
Feat.
P. Grayson
53:42
PleXus Communications
Managing Women's Health in Menopause: Evolving Approaches for t…
Feat.
J. Simon,
T. Iyer,
A. Fiffick,
M. Minkin
28:59
Scripps Health
Management of Simultaneous Venous and Arterial Thromboembolic Disease
Feat.
J. May
28:10
Indy Hematology Review
Current Review of Benign Hematology and Coagulopathy
Feat.
C. Kessler
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
13:36
Vanderbilt University Medical Center (VUMC)
Venous Thromboembolism Prophylaxis in Newly Diagnosed MM
Feat.
M. Baljevic
23:02
Cleveland Clinic Taussig Cancer Institute
Pulmonary Complications of Checkpoint Inhibitor Therapy
Feat.
M. Smith
10:27
Robert McBane
2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…
56:29
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Fred Hutchinson Cancer Center Update in Thromboembolism
Feat.
D. Garcia
51:20
Jerry Spivak
Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…
31:49
Oncology Data Advisor
Predicting Immune-Related Adverse Events Through Machine Learning
Feat.
W. Haque,
M. Hadfield,
O. Sharon
25:56
UChicago Medicine
ASH Annual Meeting Updates in Non-Malignant/Classical Hematology
Feat.
K. Cohen
19:28
OncoAlert
Cutaneous Toxicity in Oncology: Mechanism and Management
Feat.
P. Bhargava
52:19
UNC Lineberger Comprehensive Cancer Center
CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities
Feat.
M. Mcelfresh
21:32
Total Health
Hypercoagulability Work-Up and Management
Feat.
J. Chandler
13:04
Alexander Coltoff
Symptomatic Profiles of Patients With Polycythemia Vera: Implication…
45:28
McMaster University Department of Medicine
Advances in Antithrombotic Therapy: A McMaster Success Story (1970 t…
Feat.
J. Hirsch
41:34
MedNews Week
Cancer and Cardiovascular Disease: The Conjoined Twins
Feat.
R. Moudgil